epigenetics
Recuro Health Acquires 'Health Intelligence' Firm MyLifeIQ
Recuro hopes to integrate MyLifeIQ's epigenetics-based "health intelligence platform" to deliver personalized health recommendations based on DNA tests and wearable sensor data.
Burning Rock Details Plans for Cancer Monitoring Assay, Adds New Data Supporting Early Detection
Premium
Both the MRD test, BR Prophet, and a six-cancer screening assay, BR Predict, are slated for launch in China next year, initially for contracted hospital customers.
Oxford BioDynamics Awarded Grant to Apply EpiSwitch to ICI Cancer Therapy Response
The two-year PACT grant will fund the application of the EpiSwitch technology to the analysis of primary and acquired ICI resistance in several clinical trials.
Delfi Diagnostics Tags Lung Cancer as First Target for Fragmentation-Based Liquid Biopsy Tech
Premium
Based on promising early results, the company is now conducting a larger case-control study to lock in a classifier for prospective validation in an intended-use population.
Seasonal Influenza Vaccination Leads to Immune Cell Epigenomic Changes
Flu vaccinations with the AS03 adjuvant led to additional changes, including increased resistance to other, unrelated viruses.